BioCentriq

BioCentriq

Pharmaceutical Manufacturing

Newark, New Jersey 4,490 followers

Accelerating cell therapy innovation with CDMO solutions from development to commercialization.

About us

BioCentriq is a premier contract development and manufacturing organization (CDMO) dedicated to advancing cell therapy. Since 2019, the company has specialized in GMP autologous and allogeneic cell therapies, offering end-to-end clinical-to-commercial capable services tailored to clients’ unique needs. Operating from two state-of-the-art U.S.-based facilities, BioCentriq provides a comprehensive range of services, including technology transfer and new technology evaluations, process and analytical development, cGMP manufacturing, quality control lot release, and stability studies. The company’s expertise spans diverse cell therapy modalities, such as T-cell (CAR-T, TCR), NK-cell, iPSC, and MSC-based products. With its proprietary LEAP™ manufacturing platform, BioCentriq accelerates service timelines while offering standardized and customizable solutions, including traditional fee-for-service, hybrid and person-in-plant operations, dedicated cleanroom capacity, and flexible service and contract arrangements. In addition to its technical capabilities, BioCentriq operates the Cell and Gene Therapy Experiential Learning Center, a training facility which provides hands-on and virtual instruction under the guidance of industry-experienced instructors and subject matter experts. The program has trained hundreds of participants, hosted major pharmaceutical companies, and integrates next-generation technologies and concepts into its curriculum including: Industry 4.0 and Lean principles, predictive analytics, augmented reality, and electronic batch record systems. Backed by GC Corporation, a South Korea-based leader in the healthcare, pharmaceutical and biotechnology industry, BioCentriq combines global expertise with a flexible working relationship, set to empower clients to develop and deliver cutting-edge, personalized therapies with unmatched precision and efficiency.

Website
https://biocentriq.com
Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Newark, New Jersey
Type
Privately Held
Founded
2019
Specialties
CDMO, Process Development, Analytical Development, GMP Manufacture, QC Lot Release, Workforce Training & Development, Allogeneic Cell Therapy, and Autologous Cell Therapy

Locations

Employees at BioCentriq

Updates

Similar pages

Browse jobs

Funding

BioCentriq 2 total rounds

Last Round

Series A

US$ 29.2M

See more info on crunchbase